Annual report 2022

30. Mar 2023 | 1 min read

 

Moss, 30 March 2023

Gentian Diagnostics has today published its annual report for 2022. The annual report and the ESEF file is attached to this stock exchange notice and is also available on www.gentian.com.

IR contact:
Njaal Kind, CFO
njaal.kind@gentian.no 
+47 919 06 525 (mobile)

This information is subject to disclosure requirements pursuant to §5-12 of the Norwegian Securities Trading Act.


586727_5967007LIEEXZXHNM861-2022-12-31-en.zip
86727_GDASA annual report 2022.pdf

You may also read


Mar 13, 2024 - Ole Sørlie

New KDIGO Guidelines recommends increased use of cystatin C

Moss, 13 March 2024 Gentian Diagnostics (Gentian), a leading manufacturer of cystatin C, is proud to announce..

Jan 30, 2024 - Ole Sørlie

Invitation to presentation of fourth quarter results

Gentian Diagnostics ASA will present its fourth quarter 2023 results on February 9th at 09.00 am.